Efficacy of tacrolimus in ABO-incompatible kidney transplantation: clinicopathological aspect of humoral rejection.
Saito
K
K
Department of Urology, Niigata University School of Medicine, Japan.
Nakagawa
Y
Y
Tanikawa
T
T
Sonda
K
K
Nishi
S
S
Yamaguchi
Y
Y
Arakawa
M
M
Takahashi
K
K
D000017:ABO Blood-Group System; D000328:Adult; D000917:Antibody Formation; D001787:Blood Group Incompatibility; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D019520:Living Donors; D008297:Male; D010956:Plasmapheresis; D016019:Survival Analysis
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents